NCT06290726Completed
Long-term Outcomes of Living Donor Liver Transplantations With Anti-HBc (+) Grafts in Pediatric Patients
Long-term Outcomes of Active Vaccination Against de Novo Hepatitis B Among Pediatric Recipients of Living Donor Liver Transplantations With Anti-HBc (+) Grafts
Source: ClinicalTrials.gov · Last updated 5 Mar 2024
Brief summary (registry, in English)
The goal of this observational study is to compare in anti-HBc (+) grafts/ anti-HBc (-) grafts. The main question it aims to answer is the long-term efficacy of active vaccination and graft/patient outcomes of anti-HBc (+) grafts have yet to be comprehensively investigated. Researchers will compare anti-HBc (+) grafts/ anti-HBc (-) to see if it would affect the long-term survival.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 204 (actual)
- First submitted
- 26 Feb 2024
- Start date
- Feb 2002
- Primary completion date
- Feb 2016
- Lead sponsor
- Chang Gung Memorial Hospital
- Diseases
- Hepatitis B
- NCT number
- NCT06290726
What you commit to
- Study type: Observational
- Participants enrolled: 204
- From Feb 2002 to the primary completion date, Feb 2016
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Adult LDLT recipients
Who the study is looking for
- \- consecutive pediatric LDLT recipients.
Age in the registry: 4 months to 18 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.